IGFBP1 and Hyperinsulinemia: In obesity, hyperinsulinemia caused by insulin resistance leads to reduced growth hormone secretion, but IGF-I levels remain stable due to increased hepatic GH sensitivity, with suppressed IGFBP-1 levels in response to elevated insulin (24), which may decreasing the protection toward bladder cancer.